2BB score and signals
AN2 Therapeutics, Inc.’s current 2BB score is 6 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 40 | Normal |
2BBBullish & Bearish
AN2 Therapeutics, Inc. (ANTX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 6 out of 100.
AN2 Therapeutics, Inc.’s current 2BB score is 6 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 40 | Normal |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-15 | — | -0.2397 | — | $0.00 |
| 2026-11-05 | — | -0.204 | — | $0.00 |
| 2026-08-06 | — | -0.2754 | — | $0.00 |
| 2026-05-01 | — | -0.2346 | — | $0.00 |